BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1532491)

  • 61. Binding and activation of plasminogen on the platelet surface.
    Miles LA; Plow EF
    J Biol Chem; 1985 Apr; 260(7):4303-11. PubMed ID: 3920216
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Direct stimulation of urokinase, plasmin, and collagenase by meperidine: a possible mechanism for the ability of meperidine to enhance cervical effacement and dilation.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Am J Perinatol; 1993 Mar; 10(2):130-4. PubMed ID: 8476475
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Properties of three different molecular forms of the alpha 2 plasmin inhibitor.
    Clemmensen I; Thorsen S; Müllertz S; Petersen LC
    Eur J Biochem; 1981 Nov; 120(1):105-12. PubMed ID: 6458494
    [No Abstract]   [Full Text] [Related]  

  • 64. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate.
    Kulisek ES; Holm SE; Johnston KH
    Anal Biochem; 1989 Feb; 177(1):78-84. PubMed ID: 2525884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasminogen activator-anti-human fibrinogen conjugate.
    Sevilla CL; Mahle NH; Boylan CM; Callewaert DM
    Biochem Biophys Res Commun; 1985 Jul; 130(1):91-6. PubMed ID: 3161501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragment.
    Harpel PC; Sullivan R; Chang TS
    J Biol Chem; 1989 Jan; 264(1):616-24. PubMed ID: 2521222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stabilization of plasmin by lysine derivatives.
    Ueshima S; Okada K; Matsuo O
    Clin Chim Acta; 1996 Feb; 245(1):7-18. PubMed ID: 8646816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kinetic studies of the urokinase-catalysed conversion of NH2-terminal glutamic acid plasminogen to plasmin.
    Christensen U
    Biochim Biophys Acta; 1977 Apr; 481(2):638-47. PubMed ID: 139931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heat stability of plasmin (milk proteinase) and plasminogen.
    Alichanidis E; Wrathall JH; Andrews AT
    J Dairy Res; 1986 May; 53(2):259-69. PubMed ID: 2941465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inactivation of human anaphylatoxin C5a and C5a des-Arg through cleavage by the plasminogen activator activity of a human fibrosarcoma cell line.
    Higazi A al-R ; Barghouti II
    J Biol Chem; 1994 Oct; 269(41):25529-33. PubMed ID: 7929254
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.
    Christensen U; Clemmensen I
    Biochem J; 1978 Nov; 175(2):635-41. PubMed ID: 154322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medium effects on the kinetics of human plasmin.
    Yang H
    Thromb Res; 1992 Feb; 65(3):377-88. PubMed ID: 1385909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC; Clemmensen I
    Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of two laminin-binding fimbriae, the type 1 fimbria of Salmonella enterica serovar typhimurium and the G fimbria of Escherichia coli, as plasminogen receptors.
    Kukkonen M; Saarela S; Lähteenmäki K; Hynönen U; Westerlund-Wikström B; Rhen M; Korhonen TK
    Infect Immun; 1998 Oct; 66(10):4965-70. PubMed ID: 9746604
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1alpha and -1beta.
    Twining SS; Wilson PM; Ngamkitidechakul C
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):705-12. PubMed ID: 10215610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of plasmin activity by sulfated polyvinylalcohol-acrylate copolymers.
    Vörös G; Kolev K; Csomor K; Machovich R
    Thromb Res; 2000 Nov; 100(4):353-61. PubMed ID: 11113279
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 78. Peroxynitrite and fibrinolytic system: the effect of peroxynitrite on plasmin activity.
    Nowak P; Kołodziejczyk J; Wachowicz B
    Mol Cell Biochem; 2004 Dec; 267(1-2):141-6. PubMed ID: 15663195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Production of the modified form of human plasminogen in the plasma activated by urokinase.
    Yamamoto J; Okamoto U; Morita S; Kikui K; Fujii Y
    Jpn J Physiol; 1983; 33(3):469-84. PubMed ID: 6226815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A new method of isolation and some properties of the heavy chain of human plasmin.
    Rickli EE; Otavsky WI
    Eur J Biochem; 1975 Nov; 59(2):441-7. PubMed ID: 128454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.